Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Johnson  amp; Johnson to Buy Guidant for \$25.4B Health care products giant Johnson  amp; Johnson #39;s \$25.4 billion acquisition of Guidant Corp. could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
